Oncology Clinical Research
The science of clinical trials in oncology evolved to include phase I doseâ€finding trials, phase II studies to establish efficacy in a single tumor type, phase III trials comparing standards of care with potential advances in care, and phase IV studies to extend safety and activity data in a postâ€marketing scenario. As a consequence, we can expect higher cure rates in locally confined cancers and in some metastatic cancers. Investigators have substantially extended median overall survival statistics for trial subjects and patients treated off of trials who have had advanced stages of malignant diseases. An example of this extension of median overall survival in the setting of advanced, incurable disease comes from patients treated on clinical trials for advanced colorectal cancer.
In 50 years of clinical trials, median survivals have improved from 12 months in the 5â€Fluorouracil era of the 1980s to greater than 30 months in the current era where targeted therapies are combined with chemotherapy strategies across multiple lines of treatment. Oncology is a branch of prescription that arrangements with Tumours. A therapeutic expert who hones oncology is an oncologist. Integrative oncology deals with the brain, body, and soul. Modalities of development, touch, nourishment, and care are utilized inside routine disease care to address and enhance indications and personal satisfaction. That is the reason numerous experts, including medicinal specialists, have grasped the quickly extending field of integrative oncology, which melds the best of customary and option medications.
Immuno-oncology treatments enact our invulnerable framework, making it ready to perceive growth cells and annihilate them. Since tumour cells are altogether different from ordinary cells in the body, the resistant framework assaults them when it can remember them. Neuro-oncology assesses and treats individuals with essential and optional tumours of the cerebrum, spinal line, and the layers encompassing the mind and spinal rope (meninges). Oncologic Emergencies, as the term infers, are difficulties coming about because of a growth itself, a paraneoplastic disorder, or from treatment of malignancy that require prompt consideration and inversion, if conceivable. Inpatient treatment is an absolute necessity, and frequently these conditions require intercession in an escalated mind setting.
Related Conference of Oncology Clinical Research
7th International Conference on Pharmaceutical Research
&
Innovations in Pharma Industry
23rd International Conference on Medicinal and Pharmaceutical Chemistry
17th International Conference and Exhibition on Pharmacovigilance & Drug Safety
30th International Conference on Advanced Clinical Research and Clinical Trials
9th International Conference on Future Pharma and Innovations
3rd World Congress on Medicinal Chemistry and Computer Aided Drug Design
8th International Conference on Translational Medicine and Bioengineering
4th International Conference and Expo on Biopharmaceutics and Biologic Drugs
10th International Conference on Antimicrobials & Antibiotic Resistance
3rd World Conference on Pharma Industry and Medical Devices
41st International Conference on Drug Discovery and Drug delivery system
16th International Conference on Biosimilars and Pharma Innovations
Oncology Clinical Research Conference Speakers
Recommended Sessions
- Advanced Pharmaceutical Technology
- Advanced Pharmaceutics-Formulation Development
- Biomarkers in drug discovery
- Biopharmaceuticals
- Clinical Data Management
- Clinical research and clinical Trails
- Computational Chemistry in drug discovery and design
- Innovation in Drug Discovery Technology
- Medical Devices Clinical Research
- Microbiology Clinical Research
- Nano drug Delivery Syste
- Oncology Clinical Research
- Pharmaceutical Research and Development
- Pharmaceutical Sciences
- Pharmacogenomics
- Radiopharmaceuticals
- Stem Cell and Genetic Clinical Research
Related Journals
Are you interested in
- 1. Cardiovascular Medicine - Cardiovascular-2024 (France)
- 2. Hypertension - Cardiovascular-2024 (France)
- 3. Devices / CRT / ICD / Surgery - Cardiovascular-2024 (France)
- Active Pharmaceutical Ingredients - MedTech-2024 (Switzerland)
- Active Pharmaceutical Ingredients: - Pharma Research 2024 (Italy)
- Adaptive Trial Model - Clinical Trials Congress-2024 (France)
- Advanced Drug Delivery System - BIOSIMILARS-2024 (Indonesia)
- Advanced Pharmaceutical Analysis Techniques - PHARMA EDUCATION 2024 (UK)
- Advancements in Drug Discovery - Pharmacology-2024 (France)
- Advancements in Psychology Research Methods - Clinical Research 2024 (UK)
- Advances in Translational Medicine Research - Translationalmedicine2024 (Singapore)
- Advances in Vaccine Delivery - Drug Delivery-2024 (France)
- Advancing Research for rare diseases - ORPHAN DRUGS 2024 (France)
- Adverse Drug Reactions - Pharmacology 2024 (Netherlands)
- Adverse Drug Reactions - PHARMACOVIGILANCE 2024 (Italy)
- Analyses and Quality Control for Pharmaceuticals - Drug Safety 2024 (France)
- Analytical strategies for pharmaceutical products - MedTech-2024 (Switzerland)
- Analytical strategies for pharmaceutical products: - Pharma Research 2024 (Italy)
- Analytical Techniques in Bioequivalence Assessment - BABE 2024 (UAE)
- Anti-Cancer agents in Medicinal Chemistry - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Applied Pharmaceutical Sciences - PHARMA EDUCATION 2024 (UK)
- Artificial Intelligence (AI) - Personalizedmedicine-2024 (Switzerland)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- Big data analytics and Pharma - Future Pharma 2024 (Netherlands)
- Bio Chemical Pharmacology - Pharmacology 2024 (Netherlands)
- Bio-Medical Signal processing - Translationalmedicine2024 (Singapore)
- Bioavailability and Bioequivalence Studies - PHARMA EDUCATION 2024 (UK)
- Bioavailability Enhancement Strategies - BABE 2024 (UAE)
- Bioelectrical and Neural Engineering - Translationalmedicine2024 (Singapore)
- Bioengineering and Biomedical Engineering - Translationalmedicine2024 (Singapore)
- Bioequivalence and Bioavailability - MedTech-2024 (Switzerland)
- Bioequivalence and Bioavailability: - Pharma Research 2024 (Italy)
- Bioequivalence of Generic Drugs and Biosimilars - BABE 2024 (UAE)
- Bioequivalence of Narrow Therapeutic Index Drugs - BABE 2024 (UAE)
- Bioequivalence Study Designs and Methodologies - BABE 2024 (UAE)
- Bioethics and Regulatory Compliance - Clinical Research 2024 (UK)
- Bioethics and Regulatory Compliance - Clinical-Trials-2024 (Canada)
- Bioinformatics - Pharma Europe 2024 (Germany)
- Bioinformatics in Drug Discovery - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Biological Medicine - BIOSIMILARS-2024 (Indonesia)
- Biomarker Discovery and Drug Development - Clinical Trials Congress-2024 (France)
- Biomarkers - Personalizedmedicine-2024 (Switzerland)
- Biomarkers in Translational Medicine - Translationalmedicine2024 (Singapore)
- Biomaterial and Biomedical Optics - Translationalmedicine2024 (Singapore)
- Biomaterials and Biodegradable Polymers in Drug Delivery - Drug Delivery-2024 (France)
- Biomedical Devices Clinical Research - Clinical Research 2024 (UK)
- Biomedical Robotics and Mechanics - Translationalmedicine2024 (Singapore)
- Biometric And Bio Measurement - Translationalmedicine2024 (Singapore)
- Biopharmaceutical Formulation Development - Drug Delivery-2024 (France)
- Biopharmaceutical Informatics - BIOSIMILARS-2024 (Indonesia)
- Biopharmaceutical Sciences - PHARMACOVIGILANCE 2024 (Italy)
- Biopharmaceuticals, Biomolecules, and Therapeutics - Drug Safety 2024 (France)
- Biosimilars - BABE 2024 (UAE)
- Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Biotechnology and Microbiology in Pharmaceuticals - Drug Safety 2024 (France)
- Biotechnology in Pharmacotherapy - Pharmacology-2024 (France)
- Biowaivers - BABE 2024 (UAE)
- Biowaivers and Regulatory Exemptions - BABE 2024 (UAE)
- Cancer Clinical Research - Clinical Trials Congress-2024 (France)
- Cancer Genomics and Epigenomics - Translationalmedicine2024 (Singapore)
- Cancer Genomics and Epigenomics - Translationalmedicine2024 (Singapore)
- Cancer Studies: Drug Delivery Chemistry - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Cardio Vascular Pharmacology - Pharmacology 2024 (Netherlands)
- Case Report in Clinical Trials - PHARMACOVIGILANCE 2024 (Italy)
- Cellular Targeting and subcellular Delivery - Drug Safety 2024 (France)
- Challenges in GMP, GCP & Regulatory Affairs - PHARMA EDUCATION 2024 (UK)
- Challenges in Rare Diseases - ORPHAN DRUGS 2024 (France)
- Chemical and Analytical Strategies for Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Clinical and Hospital Pharmacy - Future Pharma 2024 (Netherlands)
- Clinical and Medical Case Reports - Clinical Research 2024 (UK)
- Clinical and Medical Case Reports - Pharma Europe 2024 (Germany)
- Clinical and Translational Oncology - Translationalmedicine2024 (Singapore)
- Clinical Data Base Management - PHARMACOVIGILANCE 2024 (Italy)
- Clinical Data Management and Analytics - Clinical-Trials-2024 (Canada)
- Clinical Data Management and Statistics - Clinical Research 2024 (UK)
- Clinical Data Strategy and Analytics - Clinical Trials Congress-2024 (France)
- Clinical Epidemiology - Translationalmedicine2024 (Singapore)
- Clinical Insights and Patient Outcomes - Drug Delivery 2024 (Italy)
- Clinical Operations & Project Management - Clinical-Trials-2024 (Canada)
- Clinical Pharmacology and Receptor Therapy - Clinical Trials Congress-2024 (France)
- Clinical Pharmacovigilance and Drug Safety - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Clinical Pharmacy - Pharma Europe 2024 (Germany)
- Clinical Pharmacy and Pharmacotherapeutics - Pharmacology 2024 (Netherlands)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2024 (Switzerland)
- Clinical Pharmacy and Pharmacy Practices: - Pharma Research 2024 (Italy)
- Clinical Research & Clinical Trials: Academic Perspective - Clinical-Trials-2024 (Canada)
- Clinical Research and Clinical Trials - PHARMA EDUCATION 2024 (UK)
- Clinical Research and Statistics - PHARMACOVIGILANCE 2024 (Italy)
- Clinical Research Nursing - Clinical Research 2024 (UK)
- Clinical Research Statistics - Pharmacology 2024 (Netherlands)
- Clinical Supply Management - Clinical-Trials-2024 (Canada)
- Clinical Trial Auditing - Clinical Trials Congress-2024 (France)
- Clinical Trial Forecasting, Budgeting and Contracting - Clinical-Trials-2024 (Canada)
- Clinical Trial Site Selection and Management - Clinical-Trials-2024 (Canada)
- Clinical Trials - Clinical Trials Congress-2024 (France)
- Clinical Trials - Personalizedmedicine-2024 (Switzerland)
- Clinical Trials & Pharmacovigilance - Clinical Trials Congress-2024 (France)
- Clinical Trials and Drug Evaluation - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Clinical trials and Pharmacovigilance - MedTech-2024 (Switzerland)
- Clinical trials and Pharmacovigilance: - Pharma Research 2024 (Italy)
- Clinical Trials in Developing Countries - Clinical Research 2024 (UK)
- Clinical Trials on Different Diseases - Clinical Research 2024 (UK)
- Clinical Trials on different Diseases - Clinical-Trials-2024 (Canada)
- Clinical Trials on Various Disorders - PHARMACOVIGILANCE 2024 (Italy)
- Complementary Medicine and Alternative Medicine {CAM} - Translationalmedicine2024 (Singapore)
- Computational Biology and Bioinformatics - Translationalmedicine2024 (Singapore)
- Computational Chemistry in Drug Design - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Computational Proteomics - Translationalmedicine2024 (Singapore)
- Computer Applications in Pharmacy - PHARMA EDUCATION 2024 (UK)
- Consequences of Brexit on Biosimilars - BIOSIMILARS-2024 (Indonesia)
- CRO, Sponsorship & Outsourcing for Clinical Trials - Clinical-Trials-2024 (Canada)
- Data Analytics - Personalizedmedicine-2024 (Switzerland)
- Data Quality Management and Analysis - PHARMACOVIGILANCE 2024 (Italy)
- Decentralized Clinical Trials - Clinical Trials Congress-2024 (France)
- Delivery of Medicine via Inhalation - Drug Safety 2024 (France)
- Design of Clinical Studies and Trials - Clinical Research 2024 (UK)
- Development and Production of Pharmaceutical Products - Drug Safety 2024 (France)
- Digital Health - Personalizedmedicine-2024 (Switzerland)
- Digital Health and Pharmacology - Pharmacology-2024 (France)
- Digital Marketing in Pharma Industry - Future Pharma 2024 (Netherlands)
- Digital Pharma - BIOSIMILARS-2024 (Indonesia)
- Disease Prevention - Personalizedmedicine-2024 (Switzerland)
- Diversity in Industrial Clinical Trials and Clinical Research - PHARMACOVIGILANCE 2024 (Italy)
- Drug Chemistry - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Drug delivery - Drug Devilvery 2024 (UAE)
- Drug Delivery Challenges in Neurological Disorders - Drug Delivery-2024 (France)
- Drug Delivery Strategies for Cancer Therapy - Drug Delivery-2024 (France)
- Drug Delivery Systems - Pharma Europe 2024 (Germany)
- Drug Delivery Technology - Drug Devilvery 2024 (UAE)
- Drug Delivery Technology - BIOSIMILARS-2024 (Indonesia)
- Drug Delivery Technology and Vaccine Design - Drug Safety 2024 (France)
- Drug Delivery through Blood-Brain Barrier (BBB) - Clinical Trials Congress-2024 (France)
- Drug Delivery Using Peptides and Proteins - Drug Safety 2024 (France)
- Drug Design and development - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Drug design and development - Drug Devilvery 2024 (UAE)
- Drug Designing - Clinical Trials Congress-2024 (France)
- Drug Discovery - Clinical Trials Congress-2024 (France)
- Drug Discovery and Development - Clinical-Trials-2024 (Canada)
- Drug Discovery and Development - Future Pharma 2024 (Netherlands)
- Drug discovery and NCEs - MedTech-2024 (Switzerland)
- Drug discovery and NCEs: - Pharma Research 2024 (Italy)
- Drug Discovery, Design & Development: Challenges and Approaches - PHARMA EDUCATION 2024 (UK)
- Drug Formulation - BIOSIMILARS-2024 (Indonesia)
- Drug Metabolism and Toxicology - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Drug Regulations - Pharma Europe 2024 (Germany)
- Drug Repurposing and Drug Discovery Strategies - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Drug Repurposing and Drug Rediscovery - Pharmacology-2024 (France)
- Drug Repurposing and Drug Rediscovery - Drug Delivery-2024 (France)
- Drug Research and Evaluation - Drug Safety 2024 (France)
- Drug Safety - PHARMACOVIGILANCE 2024 (Italy)
- Drug Safety - Drug Safety 2024 (France)
- Drug Safety Testing - Pharmacology 2024 (Netherlands)
- Drug Screening and Discovery - Pharmacology 2024 (Netherlands)
- Drug Synthesis and Formulation - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Drug Transporters and Bioequivalence - BABE 2024 (UAE)
- Ecopharmacovigilance - Pharmacology 2024 (Netherlands)
- Electronic Health Records (EHRs) - Personalizedmedicine-2024 (Switzerland)
- Emerging Technologies in Drug Delivery - Drug Delivery 2024 (Italy)
- Emerging Technologies in Drug Discovery - Drug Delivery-2024 (France)
- Encapsulated Drugs - BIOSIMILARS-2024 (Indonesia)
- Enrollment Planning and Patient Recruitment - PHARMA EDUCATION 2024 (UK)
- Enrollment Planning and Patient Recruitment - Clinical-Trials-2024 (Canada)
- Entrepreneurs Investment Meet - ORPHAN DRUGS 2024 (France)
- Epidemiology and Public Health - Clinical Research 2024 (UK)
- Factors that affect the quality and efficiency of clinical trials - Clinical Trials Congress-2024 (France)
- Food-Drug Interactions in Bioequivalence - BABE 2024 (UAE)
- Forensic Science and Technology - PHARMACOVIGILANCE 2024 (Italy)
- Forensic Toxicology - Pharmacology 2024 (Netherlands)
- Formulation Factors Influencing Bioavailability - BABE 2024 (UAE)
- Formulations and NNDS - MedTech-2024 (Switzerland)
- Formulations and NNDS: - Pharma Research 2024 (Italy)
- Fundamentals of Bioavailability and Bioequivalence Studies - BABE 2024 (UAE)
- Fusion of Traditional And Biomedicine - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Future Directions in Drug Delivery Research - Drug Delivery 2024 (Italy)
- Future of Clinical Trials - Clinical Research 2024 (UK)
- Future of Clinical Trials and Technology Innovations - Clinical-Trials-2024 (Canada)
- Future Perspectives in Drug Discovery and Delivery - Drug Delivery-2024 (France)
- Gaming and Abuse of Orphan Drugs - ORPHAN DRUGS 2024 (France)
- Gene Therapy and RNA-based Therapeutics - Drug Delivery-2024 (France)
- Genetic Testing - Personalizedmedicine-2024 (Switzerland)
- Genomics - Personalizedmedicine-2024 (Switzerland)
- Genomics and Proteomics of Rare Disease - ORPHAN DRUGS 2024 (France)
- Global Access and Societal Implications - Drug Delivery 2024 (Italy)
- Global Rare Diseases and Orphan Drug Market - ORPHAN DRUGS 2024 (France)
- Globalization of Clinical Trials - Clinical-Trials-2024 (Canada)
- Good Pharmacovigilance Practice - PHARMACOVIGILANCE 2024 (Italy)
- Green and Community Pharmacy - Future Pharma 2024 (Netherlands)
- Growth Strategies for Pharmaceutical Industries - PHARMA EDUCATION 2024 (UK)
- Health Equity - Personalizedmedicine-2024 (Switzerland)
- Hereditary Angioedema: Diagnosis, Clinical Implications - Clinical Trials Congress-2024 (France)
- Hospital Pharmacy & Industrial Pharmacy - PHARMA EDUCATION 2024 (UK)
- Imaging Research - Clinical Trials Congress-2024 (France)
- Immunology and Infectious Diseases - Translationalmedicine2024 (Singapore)
- Immunopharmacology - Pharmacology 2024 (Netherlands)
- Immunopharmacology of Autoimmune Disorders - Pharmacology-2024 (France)
- In Vitro-In Vivo Correlation - BABE 2024 (UAE)
- Industrial Pharmacy - Pharma Europe 2024 (Germany)
- Industrial Pharmacy and Physical pharmacy - Future Pharma 2024 (Netherlands)
- Industry Innovations and Market Trends - Drug Delivery 2024 (Italy)
- Innovations in Biomaterials for Drug Delivery - Drug Delivery 2024 (Italy)
- Innovations in clinical study designs - Clinical-Trials-2024 (Canada)
- Innovations in Clinical Trials - Clinical Research 2024 (UK)
- Innovations in Oral Drug Delivery Systems - Drug Delivery-2024 (France)
- Innovations in Pre-clinical Research - Clinical Research 2024 (UK)
- Integrative Medicine - Translationalmedicine2024 (Singapore)
- Intellectual Property Rights - BIOSIMILARS-2024 (Indonesia)
- Intellectual property rights and regulatory issues - Drug Safety 2024 (France)
- Interactive Workshops and Demonstrations - Drug Delivery 2024 (Italy)
- Latest Developments in Alzheimer’s Drugs - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Latest technologies in Biomedical Research - Clinical Research 2024 (UK)
- Lifestyle Medicine - Personalizedmedicine-2024 (Switzerland)
- Living with a Rare Disease - ORPHAN DRUGS 2024 (France)
- Medical and Clinical Case Reports - Clinical-Trials-2024 (Canada)
- Medical Devices for Drug Delivery - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Medical Imaging in Clinical Research - Clinical-Trials-2024 (Canada)
- Medicinal Chemistry - PHARMA EDUCATION 2024 (UK)
- Medicinal Chemistry - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Medicinal Chemistry and Drug Delivery - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Medicinal Chemistry: Physical Properties and Drug Design - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Microbiology Clinical Research - Clinical Research 2024 (UK)
- Modern drug delivery techniques - Drug Safety 2024 (France)
- Molecular and Clinical Pharmacology - Pharmacology 2024 (Netherlands)
- Nanotechnology Applications in Drug Delivery - Drug Delivery-2024 (France)
- Nanotechnology in Drug Delivery - Pharma Europe 2024 (Germany)
- Nanotechnology in Pharmaceuticals - PHARMA EDUCATION 2024 (UK)
- Natural Products in Drug Development - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Neuro Degenerative Disease - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Neuro Pharmacology - Pharmacology 2024 (Netherlands)
- New Advances in Drug Delivery Systems - Drug Safety 2024 (France)
- Novel Drug Delivery Systems - PHARMA EDUCATION 2024 (UK)
- Novel Drug Delivery Systems - Future Pharma 2024 (Netherlands)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2024 (Switzerland)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets: - Pharma Research 2024 (Italy)
- Novel Drug Delivery Technologies - Drug Delivery-2024 (France)
- Ocular Pharmacology - Pharmacology 2024 (Netherlands)
- Oncology Clinical Research - Clinical Research 2024 (UK)
- Orphan Drug Therapeutics - ORPHAN DRUGS 2024 (France)
- Orphan Drugs Clinical Research - ORPHAN DRUGS 2024 (France)
- Overview on Rare Diseases - ORPHAN DRUGS 2024 (France)
- Patient Concerns for Orphan Drugs - ORPHAN DRUGS 2024 (France)
- Patient Recruiting & Retention - Clinical Research 2024 (UK)
- Patient-Cantered Care - Personalizedmedicine-2024 (Switzerland)
- Patient-Centric Clinical Trials - Clinical-Trials-2024 (Canada)
- Pediatric and Geriatric Bioequivalence - BABE 2024 (UAE)
- Personalized Healthcare - Personalizedmedicine-2024 (Switzerland)
- Personalized Medicine and Drug Delivery - Drug Delivery 2024 (Italy)
- Personalized Medicines And Drugs - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Pharma and Biotech Financial Outlook - Future Pharma 2024 (Netherlands)
- Pharma Companies - Pharma Europe 2024 (Germany)
- Pharma Market Research - MedTech-2024 (Switzerland)
- Pharma Market Research: - Pharma Research 2024 (Italy)
- Pharmaceutical Analysis - Future Pharma 2024 (Netherlands)
- Pharmaceutical and healthcare Industry - Future Pharma 2024 (Netherlands)
- Pharmaceutical Biotechnology - Pharma Europe 2024 (Germany)
- Pharmaceutical Chemistry - Pharma Europe 2024 (Germany)
- Pharmaceutical Chemistry - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Pharmaceutical Chemistry - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Pharmaceutical Chemistry - Future Pharma 2024 (Netherlands)
- Pharmaceutical Chemistry - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical Drug Discovery and Nanotechnology - Clinical Trials Congress-2024 (France)
- Pharmaceutical Engineering - Pharma Europe 2024 (Germany)
- Pharmaceutical Formulation Technologies - Clinical Trials Congress-2024 (France)
- Pharmaceutical Formulations - Pharma Europe 2024 (Germany)
- Pharmaceutical Manufacturing - PHARMA EDUCATION 2024 (UK)
- Pharmaceutical Manufacturing - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical manufacturing & Pharmacoeconomics - PHARMA EDUCATION 2024 (UK)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmaceutical Manufacturing and Pharmacoeconomics: - Pharma Research 2024 (Italy)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2024 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer: - Pharma Research 2024 (Italy)
- Pharmaceutical Marketing - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Pharmaceutical Microbiology - Pharma Europe 2024 (Germany)
- Pharmaceutical Nanotechnology - Pharma Europe 2024 (Germany)
- Pharmaceutical Nanotechnology - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Pharmaceutical Organic Chemistry - Clinical Trials Congress-2024 (France)
- Pharmaceutical Packaging and Logistics - MedTech-2024 (Switzerland)
- Pharmaceutical Packaging and Logistics: - Pharma Research 2024 (Italy)
- Pharmaceutical Packing and Marketing - PHARMA EDUCATION 2024 (UK)
- Pharmaceutical Sciences - Pharma Europe 2024 (Germany)
- Pharmaceutical Sciences - Clinical-Trials-2024 (Canada)
- Pharmaceutical Sciences - MedTech-2024 (Switzerland)
- Pharmaceutical Sciences: - Pharma Research 2024 (Italy)
- Pharmaceutical Sciences: Academic and Industry Overview - PHARMA EDUCATION 2024 (UK)
- Pharmaceutical Technology - Clinical Trials Congress-2024 (France)
- Pharmaceutical Technology & Development - PHARMA EDUCATION 2024 (UK)
- Pharmaceuticals and Cosmetics - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Pharmaceuticals and Drug Delivery Systems Using Nanotechnology - Drug Safety 2024 (France)
- Pharmaceutics - Pharma Europe 2024 (Germany)
- Pharmaceutics & Pharmacotherapeutics - Future Pharma 2024 (Netherlands)
- Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmacoeconomics: - Pharma Research 2024 (Italy)
- Pharmacogenetics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenetics and Personalized Medicine - Pharmacology-2024 (France)
- Pharmacogenomics - Drug Safety 2024 (France)
- Pharmacogenomics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenomics - BIOSIMILARS-2024 (Indonesia)
- Pharmacogenomics and Personalized Medicine - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Pharmacogenomics and Personalized Medicine - BABE 2024 (UAE)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2024 (Switzerland)
- Pharmacogenomics and Pharmacoepidemiology: - Pharma Research 2024 (Italy)
- Pharmacognosy - Pharma Europe 2024 (Germany)
- Pharmacokinetic Parameters and Analysis - BABE 2024 (UAE)
- Pharmacokinetics and Pharmacodynamics - Pharmacology-2024 (France)
- Pharmacological Sciences - Pharma Europe 2024 (Germany)
- Pharmacology - Pharmacology 2024 (Netherlands)
- Pharmacology - Drug Safety 2024 (France)
- Pharmacology and new innovations - PHARMA EDUCATION 2024 (UK)
- Pharmacology and Toxicology - ORPHAN DRUGS 2024 (France)
- Pharmacology and Toxicology - MedTech-2024 (Switzerland)
- Pharmacology and Toxicology: - Pharma Research 2024 (Italy)
- Pharmacology of Addiction and Substance Abuse - Pharmacology-2024 (France)
- Pharmacology of Aging and Geriatric Medicine - Pharmacology-2024 (France)
- Pharmacology of Antimicrobial Resistance - Pharmacology-2024 (France)
- Pharmacology of Cancer Immunotherapy - Pharmacology-2024 (France)
- Pharmacology of Cardiovascular Therapeutics - Pharmacology-2024 (France)
- Pharmacology of Neurodegenerative Disorders - Pharmacology-2024 (France)
- Pharmacology of Nutraceuticals and Dietary Supplements - Pharmacology-2024 (France)
- Pharmacology of Pain Management and Analgesia - Pharmacology-2024 (France)
- Pharmacology of Rare Diseases - Pharmacology-2024 (France)
- Pharmacology of Respiratory Diseases: - Pharmacology-2024 (France)
- Pharmacovigilance - Clinical Trials Congress-2024 (France)
- Pharmacovigilance and Drug Safety - Clinical Research 2024 (UK)
- Pharmacovigilance and Drug Safety - Clinical-Trials-2024 (Canada)
- Pharmacovigilance and Risk Management - PHARMA EDUCATION 2024 (UK)
- Pharmacovigilance and Risk Management - PHARMACOVIGILANCE 2024 (Italy)
- Pharmacovigilance in the Era of Big Data - Pharmacology-2024 (France)
- Pharmacovigilance Significance & Scope - PHARMACOVIGILANCE 2024 (Italy)
- Pharmacovigilance Significance and Scope - Pharmacology 2024 (Netherlands)
- Pharmacy Development Services - Pharma Europe 2024 (Germany)
- Pharmacy Practices and its Challenges - PHARMACOVIGILANCE 2024 (Italy)
- Population Health - Personalizedmedicine-2024 (Switzerland)
- Post Marketing Surveillance - Clinical Trials Congress-2024 (France)
- Post-Clinical Trial closed communities - Clinical Trials Congress-2024 (France)
- Pre-clinical and Clinical Trails - Pharmacology 2024 (Netherlands)
- Pre-Clinical and Clinical Trials - PHARMACOVIGILANCE 2024 (Italy)
- Precision Medicine - Personalizedmedicine-2024 (Switzerland)
- Preformulation Research - Drug Safety 2024 (France)
- Process Chemistry - PHARMA EDUCATION 2024 (UK)
- PV Consulting’s and Business opportunity - PHARMACOVIGILANCE 2024 (Italy)
- QC & QA: Quality control and Quality assurance - MedTech-2024 (Switzerland)
- QC & QA: Quality control and Quality assurance: - Pharma Research 2024 (Italy)
- Quality by design(QbD) approach - Pharma Research 2024 (Italy)
- Quality by design(QbD) approach - MedTech-2024 (Switzerland)
- Radiation-based medicines and biotherapy - Drug Safety 2024 (France)
- Radiopharmaceuticals - PHARMA EDUCATION 2024 (UK)
- Rare Diseases and Ultra Rare Diseases - ORPHAN DRUGS 2024 (France)
- Rare Genetic Diseases/Disorder - ORPHAN DRUGS 2024 (France)
- Real-World Evidence in Clinical Trials - Clinical Research 2024 (UK)
- Real-World Evidence in Clinical Trials - Pharma Europe 2024 (Germany)
- Recent advances in drug delivery - Drug Devilvery 2024 (UAE)
- Recent Advances in Nanotechnology for Drug Delivery - Drug Delivery 2024 (Italy)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2024 (Netherlands)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2024 (Netherlands)
- Regenerative Medicine and Tissue Engineering - Drug Delivery-2024 (France)
- Regulatory Affairs - PHARMACOVIGILANCE 2024 (Italy)
- Regulatory Affairs and Intellectual Property Rights - Future Pharma 2024 (Netherlands)
- Regulatory Affairs in Pharmaceutical Industry - PHARAMACEUTICAL CONF 2024 (Indonesia)
- Regulatory Authority Compliance - MedTech-2024 (Switzerland)
- Regulatory Authority Compliance: - Pharma Research 2024 (Italy)
- Regulatory Considerations in Drug Development - Drug Delivery-2024 (France)
- Regulatory Pathways and Compliance in Drug Delivery - Drug Delivery 2024 (Italy)
- Research and development in pharmaceuticals - Drug Safety 2024 (France)
- Research and Trials on Oncology and AIDS - Clinical-Trials-2024 (Canada)
- Revolutionary Changes - ORPHAN DRUGS 2024 (France)
- Role of Translational Research in Blood Disorder - Translationalmedicine2024 (Singapore)
- Safety of drugs and pharmacovigilance - Drug Safety 2024 (France)
- Safety Pharmacology - Pharmacology 2024 (Netherlands)
- Site Management Innovation - Clinical Research 2024 (UK)
- Stem Cell and Genetic Clinical Research - Clinical Research 2024 (UK)
- Stem Cells and Regenerative Medicine - Translationalmedicine2024 (Singapore)
- Structure-based drug design, virtual screening - PHARMA MEDICINAL CHEMISTRY 2024 (Canada)
- Targeted Therapies - Personalizedmedicine-2024 (Switzerland)
- Technologies for Formulation - Drug Safety 2024 (France)
- Technology in Pharma Sciences - MedTech-2024 (Switzerland)
- Technology in Pharma Sciences: - Pharma Research 2024 (Italy)
- Telemedicine - Personalizedmedicine-2024 (Switzerland)
- The BBB for drug delivery - Drug Safety 2024 (France)
- The Future of Pharma R&D - Future Pharma 2024 (Netherlands)
- Therapeutic Drug Transporters - Drug Safety 2024 (France)
- Toxicology - Pharmacology 2024 (Netherlands)
- Translational Bioinformatics - Translationalmedicine2024 (Singapore)
- Translational Cardiology and Vascular Medicine - Translationalmedicine2024 (Singapore)
- Translational Medicine - Translationalmedicine2024 (Singapore)
- Translational of Animal Models to the Clinic - Translationalmedicine2024 (Singapore)
- Translational Research - Personalizedmedicine-2024 (Switzerland)
- Translational Therapeutics and Technologies - Translationalmedicine2024 (Singapore)